Translate this page to:
Arabic
In JoVE (1)
Other Publications (3)
Automatic Translation
This translation into Arabic was automatically generated.
English Version | Other Languages
Articles by Heinrich H. Bülthoff in JoVE
JoVE Neuroscience
MPI سيبرموتيون محاكي: تنفيذ جهاز محاكاة الحركة الرواية المعنية بالتحقيق في مسار التكامل متعدد الحواس في ثلاثة أبعاد
1Department of Human Perception, Cognition and Action, Max Planck Institute for Biological Cybernetics, 2Laboratoire de Physiologie de la Perception et de l'Action, Collège de France - CNRS, 3Department of Brain and Cognitive Engineering, Korea University
وصفت وسيلة فعالة لاكتساب المعرفة في كيفية انتقال البشر أنفسهم في ثلاثة أبعاد. طريقة يستفيد من جهاز محاكاة حركة قادرة على نقل المراقبين بطرق غير قابلة للتحقيق من قبل أجهزة المحاكاة التقليدية. تؤكد النتائج التي يتم التقليل من شأن الحركة في المستوى الأفقي، في حين يتم المبالغة في تقدير الحركة العمودية.
Other articles by Heinrich H. Bülthoff on PubMed
[Retroperitoneal Sarcomas: a Single Center Experience]
To analyse the management and clinical outcome of patients treated for retroperitonal soft tissue sarcoma and to identify prognosis factors.
Application of UV-spectrophotometric Methods for Estimation of Tenofovir Disoproxil Fumarate in Tablets
Two new, simple and cost effective UV-spectrophotometric and first order derivative methods were developed for estimation of tenofovir disoproxil fumarate in bulk and tablets. Tenofovir disoproxil fumarate was estimated at 260 nm in 0.1N HCl. In first order derivative, it showed amplitude at 273 nm. In both the methods linearity was found to be in the range of 5-40 micro/ ml; for UV-spectrophotometric method (Y=0.02586 x +0.0083; r(2)=0.9999) and for first order derivative spectrophotometric method (Y=0.00132 x +0.00035; r(2)=0.9995), respectively. These methods were tested and validated for various parameters according to USP guidelines. The quantitation limits were found to be 1.546 and 1.986 micro/ ml, for both the methods. The proposed methods were successfully applied for the determination of tenofovir disoproxil fumarate in pharmaceutical formulations. The results demonstrated that the procedure is accurate, precise and reproducible (relative standard deviation <2%), while being simple, cheap and less time consuming and can be suitably applied for the estimation of tenofovir disoproxil fumarate in different dosage forms.
